REEV

REEV is a medical technology company developing wearable robotics and gait-assessment tools for people with neurological gait disorders, including patients after stroke, with multiple sclerosis or paraplegia. Its product platform has two components. REEV SENSE is a connected motion-sensor system attached to a patient's shoes, thigh, calf or ankle that feeds a mobile application; it produces spatio-temporal metrics (speed, cadence, stride length, swing and stance time, stance symmetry), knee and ankle flexion kinematics, and built-in timing and logging for standard clinical tests (TUG, 5xSTS, 10MWT, 6MWT), generating PDF gait reports in under two minutes with data export to practice-management systems. DREEVEN is an AI-powered motorized knee orthosis that uses electro-hydraulic technology to motorize passive knee-ankle-foot orthoses (KAFO) and deliver personalized knee assistance; gait signatures captured by REEV SENSE are imported into DREEVEN to tune its motor control.

The company positions the two products as a single mobility platform for outpatient clinics: assessment first, then robotic assistance. REEV SENSE is described as FDA registered and CE certified (CE/FDA Class 1), HIPAA/GDPR compliant with data stored on HDS servers, and validated against motion-capture laboratories on more than 50 subjects. DREEVEN is at the clinical-study stage, with work at Boston University's Neuromotor Recovery Lab and preparation for U.S. FDA trials.

REEV operates from Toulouse/Labège in France (REEV SAS, 445 L'Occitane, 31670 Labège) and Cambridge, Massachusetts in the United States (REEV LLC, 20 University Rd, Cambridge, MA 02138), with a team described as 30 people across Toulouse and Boston.

Founding story

REEV grew out of a student project led by Amaury Ciurana, an aerospace engineer trained at ISAE-SUPAERO with entrepreneurial programs at HEC Paris, École polytechnique and UC Berkeley, who won the 1M euro Lopez-Loreta Prize. He co-founded the company in 2021 with Robin Temporelli, a mechatronics engineer from INSA Toulouse with a Ph.D. from the University of Sherbrooke and prior engineering roles at Safran, CTA-BRP and Airbus Defence and Space.

Business model

REEV sells its mobility platform to outpatient clinics and rehabilitation providers: REEV SENSE is commercialized to healthcare professionals through quotes and free trials, with a partner network for clinics, while DREEVEN, the motorized knee orthosis, is being prepared for launch through early-adopter and clinical partnerships.

Traction

REEV SENSE is reported as clinically validated on more than 50 subjects, with 95% precision on spatio-temporal measures and under 5 degrees mean absolute error on kinematics versus motion-capture laboratories, and was built after a year of market testing with medical centers. Company posts describe a pivotal clinical study of DREEVEN for post-stroke mobility with Encompass Health, Whittier Rehabilitation Hospital (Bradford, MA) and Boston University, and the expansion of a Neuro-Integration Program adding Jefferson Moss-Magee Rehabilitation, Community Health System and DHR Health.

Latest developments

Company news items report the launch of a pivotal clinical study of DREEVEN for post-stroke mobility with Encompass Health, Whittier Rehabilitation Hospital in Bradford, MA and Boston University, and the doubling of REEV's Neuro-Integration Program within four months with the addition of Jefferson Moss-Magee Rehabilitation, Community Health System and DHR Health.